Article Type
Article
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Comparing COPD Combination Treatments

Article PDF
022090032_0.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 22(9)
Publications
Federal Practitioner
Page Number
32
Legacy Keywords
respiratory disease, COPD, chronic obstructive pulmonary disease, fluticasone propionate/salmeterol, FSC, ipratropium bromide/albuterol sulfate, IB/ALB, treatmentrespiratory disease, COPD, chronic obstructive pulmonary disease, fluticasone propionate/salmeterol, FSC, ipratropium bromide/albuterol sulfate, IB/ALB, treatment
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
022090032_0.pdf
Article PDF
022090032_0.pdf

Issue
Federal Practitioner - 22(9)
Issue
Federal Practitioner - 22(9)
Page Number
32
Page Number
32
Publications
Federal Practitioner
Publications
Federal Practitioner
Article Type
Article
Display Headline
Comparing COPD Combination Treatments
Display Headline
Comparing COPD Combination Treatments
Legacy Keywords
respiratory disease, COPD, chronic obstructive pulmonary disease, fluticasone propionate/salmeterol, FSC, ipratropium bromide/albuterol sulfate, IB/ALB, treatmentrespiratory disease, COPD, chronic obstructive pulmonary disease, fluticasone propionate/salmeterol, FSC, ipratropium bromide/albuterol sulfate, IB/ALB, treatment
Legacy Keywords
respiratory disease, COPD, chronic obstructive pulmonary disease, fluticasone propionate/salmeterol, FSC, ipratropium bromide/albuterol sulfate, IB/ALB, treatmentrespiratory disease, COPD, chronic obstructive pulmonary disease, fluticasone propionate/salmeterol, FSC, ipratropium bromide/albuterol sulfate, IB/ALB, treatment
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media